This article is from the source 'guardian' and was first published or seen on . The next check for changes will be

You can find the current article at its original source at https://www.theguardian.com/us-news/2025/may/18/joe-biden-prostate-cancer-diagnosis

The article has changed 6 times. There is an RSS feed of changes available.

Version 0 Version 1
Joe Biden diagnosed with ‘aggressive form’ of prostate cancer, his office says Joe Biden diagnosed with ‘aggressive form’ of prostate cancer, his office says
(33 minutes later)
Former US president is reviewing treatment options with family as cancer has spread to the boneFormer US president is reviewing treatment options with family as cancer has spread to the bone
Joe Biden has been diagnosed with prostate cancer, which has spread to the bone, and the former president and his family are reviewing treatment options, his office said in a statement on Sunday.Joe Biden has been diagnosed with prostate cancer, which has spread to the bone, and the former president and his family are reviewing treatment options, his office said in a statement on Sunday.
“While this represents a more aggressive form of the disease, the cancer appears to be hormone-sensitive which allows for effective management,” his office said. “The President and his family are reviewing treatment options with his physicians.”
Prostate cancers are given a score called a Gleason score that measures, on a scale of one to 10, how the cancerous cells look compared with normal cells. Biden’s office said his score was nine, suggesting his cancer is among the most aggressive.
When prostate cancer spreads to other parts of the body, it often spreads to the bones. Metastasized cancer is much harder to treat than localized cancer because it can be hard for drugs to reach all the tumors and completely root out the disease.
However, when prostate cancers need hormones to grow, as in Biden’s case, they can be susceptible to treatment that deprives the tumors of hormones.
Biden, 82, beat an incumbent Donald Trump in the 2020 presidential election and initially sought a rematch with him last year. But, amid questions about his age and mental acuity, he dropped out of the race and endorsed his vice-president, Kamala Harris, to succeed him.Biden, 82, beat an incumbent Donald Trump in the 2020 presidential election and initially sought a rematch with him last year. But, amid questions about his age and mental acuity, he dropped out of the race and endorsed his vice-president, Kamala Harris, to succeed him.
Trump, who is just three years younger than Biden, subsequently defeated Harris in November’s election and returned to the White House in January.Trump, who is just three years younger than Biden, subsequently defeated Harris in November’s election and returned to the White House in January.
Biden has dealt with cancer before. Prior to starting his presidency, he had several non-melanoma skin cancers surgically removed, and he had a cancerous lesion removed from his chest in February 2023.Biden has dealt with cancer before. Prior to starting his presidency, he had several non-melanoma skin cancers surgically removed, and he had a cancerous lesion removed from his chest in February 2023.
In the US, prostate cancer is the most common cancer and the second leading cause of cancer death among men, according to the American Cancer Society.In the US, prostate cancer is the most common cancer and the second leading cause of cancer death among men, according to the American Cancer Society.
Sunday’s statement from Biden’s office said the former president’s diagnosis represented “a more aggressive form” of cancer, though it “appears to be hormone-sensitive, which allows for effective management”. In 2022, Biden made a “cancer moonshot” one of his administration’s priorities, with the goal of halving the cancer death rate over the next 25 years. The initiative was a continuation of his work as vice-president to address a disease that had killed his older son, Beau.
More details soon …
Reuters and the Associated Press contributed reporting.Reuters and the Associated Press contributed reporting.